(Registrieren)

Symbol Technologies Introduces Premium In-Counter Mini-Slot Scanner for Retail Environments

Geschrieben am 03-10-2006

Holtsville, New York (ots/PRNewswire) -

- LS7808 Offers Superior Performance for Enhanced Customer Service

Symbol Technologies, Inc. (NYSE: SBL), The Enterprise Mobility
Company(TM), today introduced a new in-counter mini-slot scanner for
increased productivity in high-traffic retail environments.
Incorporating omni-directional scanning to eliminate the need to
orient the bar code for faster and more accurate read rates on even
the most poorly printed bar codes, the LS7808 scanner can help
improve customer service with reduced checkout times.

(Logo: http://www.newscom.com/cgi-bin/prnh/20041029/SYMBOLOGO )

"Symbol has been designing, selling and supporting bar code
scanners for more than 30 years and was a pioneering developer of
Visible Laser Diode (VLD) based horizontal mini-slot scanners," said
Bob Sanders, vice president and general manager of Symbol's advanced
data capture division. "The new LS7808 scanner builds on this rich
heritage with advanced technologies that enable cashiers to focus on
customers instead of the products being scanned."

Designed for the most demanding retail environments, the
high-performance LS7808 offers hands-free scanning for fast and
accurate read rates, with minimal cashier effort. The LS7808 provides
intuitive, productivity-enhancing functionality that allows novice
and advanced users alike to move customers quickly through checkout
and increase customer satisfaction rates at the retail point-of-sale.
Symbol's advanced software algorithms allow customers using the
LS7808 scanner to quickly and accurately scan one-dimensional (1D)
bar codes including those that are damaged, small or poorly printed
to help improve operational efficiencies.

For additional productivity, Symbol customers can connect a
secondary handheld scanner to the LS7808 for flexibility in scanning
large and oversized items at checkout without having to lift them
from the shopping cart. With its sleek design to save space on the
countertop, the new LS7808 scanner is also available with
scratch-proof glass and a stainless steel encasement to prevent
scanner damage -- especially in grocery and home improvement
environments where continued exposure to cans and other hard metal
items can potentially damage a system.

To help customers protect their investment and maintain peak
performance, Symbol Global Services offers Service from the Start
with Comprehensive Coverage for the LS7808. This unique service goes
far beyond normal wear and tear to include accidental damage to exit
windows, scan elements and more at no additional charge -- virtually
eliminating unforeseen repair expenses. On-site options are also
available for maximum response with minimum service interruption.

The Symbol LS7808 mini-slot scanner is currently available to
order globally through Symbol partners.

About Symbol Technologies

Symbol Technologies, Inc., The Enterprise Mobility Company(TM), is
a recognized worldwide leader in enterprise mobility, delivering
products and solutions that capture, move and manage information in
real time to and from the point of business activity. Symbol
enterprise mobility solutions integrate advanced data capture
products, radio frequency identification technology, mobile computing
platforms, wireless infrastructure, mobility software and world-class
services programs under the Symbol Enterprise Mobility Services
brand. Symbol enterprise mobility products and solutions are proven
to increase workforce productivity, reduce operating costs, drive
operational efficiencies and realize competitive advantages for the
world's leading companies. More information is available at
http://www.symbol.com.

For Symbol Technologies:
For media information:
Traci Hoch Betsy Blicharz
Symbol Technologies, Inc. Edelman Public Relations
+1-631-738-5426 +1-212-704-4484
traci.hoch@symbol.com elizabeth.blicharz@edelman.com
For financial information: For industry analyst information:
Lori Chaitman Shirley Schroedl
Symbol Technologies, Inc. Symbol Technologies, Inc.
+1-631-738-5050 +1-631-738-4823
lori.chaitman@symbol.com shirley.schroedl@symbol.com

Web site: http://www.symbol.com

ots Originaltext: Symbol Technologies, Inc.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For media information: Betsy Blicharz of Edelman Public Relations,
+1-212-704-4484, elizabeth.blicharz@edelman.com, for Symbol
Technologies; or Traci Hoch, +1-631-738-5426, traci.hoch@symbol.com,
or for financial information: Lori Chaitman, +1-631-738-5050,
lori.chaitman@symbol.com, or for industry analyst information:
Shirley Schroedl, +1-631-738-4823, shirley.schroedl@symbol.com, all
of Symbol Technologies, Inc. Photo:
http://www.newscom.com/cgi-bin/prnh/20041029/SYMBOLOGO


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

32702

weitere Artikel:
  • MacroChem beginnt Phase II-Versuchsreihe mit lokal antimykotischem EcoNail(TM)-Lack Wellesley Hills, Massachusettes (ots/PRNewswire) - MacroChem Corporation (OTC- Bulletin Board: MACM) hat mit der Aufnahme von Patienten mit Onychomykose, einer Pilzinfektion der Finger- und Fussnägel, zu einer Phase II-Versuchsreihe von EcoNail(TM) begonnen. MacroChem geht davon aus, etwa 40 Patienten in dieser multizentrischen Open-Label-Versuchsreihe in den USA aufzunehmen. Patienten, die an der Versuchsreihe teilnehmen, welche unter dem US-amerikanischen IND-Status von MacroChem durchgeführt wird, werden 48 Wochen lang behandelt und Wirksamkeitsbeurteilungen mehr...

  • Oncalis AG und ChemDiv Inc. gehen umfassende, weitreichende Partnerschaft ein Zürich, Schweiz und San Diego (ots/PRNewswire) - Oncalis AG aus Schlieren in der Schweiz und ChemDiv Inc. aus San Diego geben eine weitreichende Zusammenarbeit in Forschung und Entwicklung bekannt. Oncalis wird seine firmeneigene, auf Hefezellen basierende Technologie einsetzen und biologische Assays entwickeln und ChemDiv wird medizinchemische und biologische in vitro und in vivo Dienstleistungen erbringen, um Kandidaten für Rezeptor-Tyrosine-Kinase-Inhibitoren und andere krebsbezogene Zielmoleküle zu entwickeln. Oncalis AG ist kürzlich mehr...

  • Isotechnika Receives European Patent for Lead Immunosuppressive Drug, ISA247 Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the Company has been issued European Patent No. EP0991660 for its lead immunosuppressive drug, ISA247. The patent entitled "DEUTERATED AND UNDEUTERATED CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS" is the ninth patent to be issued internationally in this patent family. Patents relating to these claims have issued in the following countries; Australia (No. 750245, issued July 11, 2002 and No. 774744 issued October 21, 2004), Canada (No. 2,298,572 mehr...

  • Norsemont Reports 1.23 Billion Pounds of Copper as Inferred Resources Plus 749 Million Pounds as Indicated Resources With Significant Molybdenum and Silver at the Constancia Project Vancouver, Canada (ots/PRNewswire) - - CONFERENCE CALL AT 11.00AM (PT), OCTOBER 4, 2006 - TSX-V: NOM Norsemont Mining Inc. ("Norsemont" or "the Company") (TSX-V: NOM; Frankfurt: N8S; WKN: A0DQKK; OTC-BB: NOMFF; ISIN: CA6565291045) is pleased to announce results of an Initial Resource Estimate on the Constancia Copper-Molybdenum-Silver Porphyry Project in southern Peru. An independent mineral resource estimate has been completed on the Constancia and San Jose Zones of the Constancia Project in Southern Peru. The report estimates mehr...

  • Xenomics liefert Business-Update in WallStreetReporter Interview New York (ots/PRNewswire) - - CEO über proprietäre DNA-Technologie, Produktentwicklungsinitiativen und neue Vorstandsmitglieder Xenomics, Inc. (OTC Bulletin Board: XNOM; FWB:XE7), die Quelle der nächsten Generation von medizinischen DNA-Tests, gab kürzlich im Rahmen eines Interviews mit WallStreetReporter ein umfassendes Business-Update. Dr. David Tomei, CEO und einer der Gründer von Xenomics, sprach über die proprietäre DNA-Diagnosetechnologie, Produktentwicklungsinitiativen und über Dr. David Sidransky, ein neues Mitglied im Board mehr...

Mehr zu dem Thema Aktuelle Wirtschaftsnews

Der meistgelesene Artikel zu dem Thema:

DBV löst Berechtigungsscheine von knapp 344 Mio. EUR ein

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht